Mount Yale Investment Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,103
Closed -$296K 493
2022
Q1
$296K Hold
4,103
0.03% 370
2021
Q4
$377K Hold
4,103
0.04% 329
2021
Q3
$520K Hold
4,103
0.06% 277
2021
Q2
$682K Sell
4,103
-163
-4% -$26.4K 0.08% 230
2021
Q1
$775K Sell
4,266
-1,117
-21% -$259K 0.1% 212
2020
Q4
$1.08M Buy
+5,383
New +$1.09M 0.15% 153
2018
Q4
Sell
-273
Closed -$19K 724
2018
Q3
$19K Buy
+273
New +$19.5K ﹤0.01% 793

Other funds holding TDOC

Mount Yale Investment Advisors's TDOC Position: Q2 2022 in Review

Mount Yale Investment Advisors sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 4,103 shares — an estimated $296K sold.

Mount Yale Investment Advisors first reported a position in TDOC in Q3 2018 and held it in 7 quarters. The position peaked at $1.08M in Q4 2020. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Mount Yale Investment Advisors reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 4,103 Teladoc Health shares in Q2 2022, an estimated $296K.
  • Mount Yale Investment Advisors first reported a position in Teladoc Health in Q3 2018 and held it in 7 quarters.
  • Mount Yale Investment Advisors's Teladoc Health position peaked at $1.08M in Q4 2020.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Mount Yale Investment Advisors's 13F filing for Q2 2022, filed 2 Aug 2022.